HOPE Therapeutics starts deploying FDA-cleared robotic TMS system
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
11:01:17 AM UTC
SquawkNews
WILMINGTON, Del., Sept. 11, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. NASDAQ:NRXP ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, today announced that its subsidiary, HOPE Therapeutics, Inc. ("HOPE"), will be the first Interventional Psychiatry…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.